MannKind Corp.
Link ID 246383
Title MannKind Corp.
Url http://www.mannkindcorp.com/
Description Developing a pulmonary insulin delivery system, and immunotherapy of cancer, by identifying tumor-related antigens, DNA and peptide-based drugs evoking cell-mediated responses. Located in Valencia, California.
Category Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development
Keywords
Date Jul 19, 2006
Contact Name
Email
Add to My Favorite   Refer it to Friend   Report Broken Link  


 Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development
1. Endocube
  Engaged in the identification, validation and selection of novel drugable targets and product candidates for the diagnosis and treatment of chronic inflammatory diseases. Profiles of technology, product pipeline and corporation in Labege, France.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


2. AVI Biopharma, Inc.
  Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular, kidney and viral diseases. Research and manufacturing facilities in Corvallis, Oregon. (Nasdaq: AVII)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


3. Praecis Pharmaceuticals Inc.
  Develops peptide-based therapeutics for the treatment of human hormone diseases, prostate cancer endometriosis, and inflammatory diseases. Includes therapeutic targets and profile of facilities in Waltham, Massachusetts. (Nasdaq: PRCS)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


4. Sierra Sciences Inc.
  Developing drugs and therapies to reverse the effects of human aging by focusing on preserving the length of telomeres, to keep them more resilient. Careers in Reno, Nevada.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


5. Imclone Systems Inc.
  Researches and develops growth factor blockers and anti-cancer vaccines. Includes clinical programs, investor details and overview of company in New York City. (Nasdaq: IMCL)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development




Home      New Listings      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing     Disclaimer
Copyright © internet-directory.com 1999-2023

Sponsors